Medication or Drug adherence refers to the extent to which a person’s medication-taking behavior aligns with the recommendations provided by their healthcare provider. Adherence to medications averages around 50% among patients with chronic diseases. This...
Five years into his Alzheimer’s and Dementia diagnosis, David Rothman had lost the ability to communicate. Silent and unresponsive, he seemed unreachable. But in 2023, a serendipitous moment changed everything. While in the lobby of...
A groundbreaking test known as qBEANS (Quick Behavioral Exam to Advance Neuropsychological Screening) is showing immense potential in identifying Alzheimer's disease early, as presented at the 2024 Gerontological Society of America Annual Scientific Meeting.
Recent findings from the American Heart Association (AHA) reveal critical insights into how cardiovascular conditions like heart failure (HF), atrial fibrillation (AF), and coronary heart disease (CHD) may heighten the risk for cognitive decline and...
Patients experiencing memory lapses often find themselves seeking a second opinion, especially when referred to specialists like Dr. David Jones, a neurologist at Mayo Clinic in Rochester, Minnesota. Many of these patients exhibit common memory...
Recent research has indicated that frequent nightmares in middle age may be linked to a significantly increased risk of developing dementia. This finding, while compelling, has generated some skepticism among experts in the field.
Recent data presented at the American Geriatrics Society (AGS) 2024 Annual Scientific Meeting highlights the widespread use of medications that negatively affect cognition among older adults with dementia. The study analyzed data from approximately 13...
I am now an octogenarian. In talking with my 80-something friends, we all agree that it would be far more dignified to die in a few moments from a massive heart attack or stroke, than...
In 2019, the estimated number of global dementia cases totaled 57.4 million. That number is expected to nearly triple by 2050. Given the predicted surge in incidence, and the lack of substantial treatment options, research...
• Donepezil (Aricept, Adlarity) is a first-line treatment for dementia caused by Alzheimer's disease. It can help those who have mild, moderate, or severe disease. • Aricept is a brand of donepezil that is taken orally. It comes...
